General Information
Revision date
2014-11-25
Product name
Phenoxybenzamine Hydrochloride Capsules USP
CAS No.
63-92-3
1.2.1 Relevant identified uses
Treatment of pheochromocytoma, to control episodes of hypertension and sweating
Icons in SDS
Company Information
company name
West-Ward Pharmaceuticals Corporation
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified
Health hazards
Carcinogenicity Category 2
Signal word
Warning
Hazard statements
Suspected of causing cancer. This is a pharmaceutical product designed to be prescribed by a licensed health care professional. Should any person while using this product observe any adverse health effects, they should seek medical treatment.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood.
Response
If exposed or concerned: Get medical advice/attention.
Storage
Store locked up. Store away from incompatible materials. Store at 25ºC (77ºF); excursions permitted to 15 - 30 °C (59 - 86 ºF).
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Incineration of waste at an approved USEPA incinerator is recommended. Hazard(s) not otherwise None known. classified (HNOC)
2.1 Classification of the substance or mixture
Not classified. Health hazards Carcinogenicity Category 2 OSHA defined hazards Not classified.
